Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Molecular determinants of acidic pH-dependent transport of human equilibrative nucleoside transporter 3.
Rahman MF
,
Askwith C
,
Govindarajan R
.
???displayArticle.abstract???
Equilibrative nucleoside transporters (ENTs) translocate hydrophilic nucleosides across cellular membranes and are essential for salvage nucleotide synthesis and purinergic signaling. Unlike the prototypic human ENT members hENT1 and hENT2, which mediate plasma membrane nucleoside transport at pH 7.4, hENT3 is an acidic pH-activated lysosomal transporter partially localized to mitochondria. Recent studies demonstrate that hENT3 is indispensable for lysosomal homeostasis, and that mutations in hENT3 can result in a spectrum of lysosomal storage-like disorders. However, despite hENT3's prominent role in lysosome pathophysiology, the molecular basis of hENT3-mediated transport is unknown. Therefore, we sought to examine the mechanistic basis of acidic pH-driven hENT3 nucleoside transport with site-directed mutagenesis, homology modeling, and [3H]adenosine flux measurements in mutant RNA-injected Xenopus oocytes. Scanning mutagenesis of putative residues responsible for pH-dependent transport via hENT3 revealed that the ionization states of Asp-219 and Glu-447, and not His, strongly determined the pH-dependent transport permissible-impermissible states of the transporter. Except for substitution with certain isosteric and polar residues, substitution of either Asp-219 or Glu-447 with any other residues resulted in robust activity that was pH-independent. Dual substitution of Asp-219 and Glu-447 to Ala sustained pH-independent activity over a broad range of physiological pH (pH 5.5-7.4), which also maintained stringent substrate selectivity toward endogenous nucleosides and clinically used nucleoside drugs. Our results suggest a putative pH-sensing role for Asp-219 and Glu-447 in hENT3 and that the size, ionization state, or electronegative polarity at these positions is crucial for obligate acidic pH-dependent activity.
Achilonu,
Role of individual histidines in the pH-dependent global stability of human chloride intracellular channel 1.
2012, Pubmed
Achilonu,
Role of individual histidines in the pH-dependent global stability of human chloride intracellular channel 1.
2012,
Pubmed
Al-Haggar,
Novel homozygous SLC29A3 mutations among two unrelated Egyptian families with spectral features of H-syndrome.
2015,
Pubmed
Ames,
Protein-protein interaction in transport: periplasmic histidine-binding protein J interacts with P protein.
1976,
Pubmed
Baldwin,
The equilibrative nucleoside transporter family, SLC29.
2004,
Pubmed
Baldwin,
Functional characterization of novel human and mouse equilibrative nucleoside transporters (hENT3 and mENT3) located in intracellular membranes.
2005,
Pubmed
,
Xenbase
Barnes,
Distribution and functional characterization of equilibrative nucleoside transporter-4, a novel cardiac adenosine transporter activated at acidic pH.
2006,
Pubmed
,
Xenbase
Boswell-Casteel,
FUN26 (function unknown now 26) protein from saccharomyces cerevisiae is a broad selectivity, high affinity, nucleoside and nucleobase transporter.
2014,
Pubmed
Campeau,
Whole-exome sequencing identifies mutations in the nucleoside transporter gene SLC29A3 in dysosteosclerosis, a form of osteopetrosis.
2012,
Pubmed
Cano-Soldado,
Functional analysis of the human concentrative nucleoside transporter-1 variant hCNT1S546P provides insight into the sodium-binding pocket.
2012,
Pubmed
Cauët,
Histidine-Aromatic Interactions in Proteins and Protein-Ligand Complexes: Quantum Chemical Study of X-ray and Model Structures.
2005,
Pubmed
Cliffe,
SLC29A3 gene is mutated in pigmented hypertrichosis with insulin-dependent diabetes mellitus syndrome and interacts with the insulin signaling pathway.
2009,
Pubmed
Colmenero,
Emperipolesis: an additional common histopathologic finding in H syndrome and Rosai-Dorfman disease.
2012,
Pubmed
Di Russo,
pH-Dependent conformational changes in proteins and their effect on experimental pK(a)s: the case of Nitrophorin 4.
2012,
Pubmed
Dougherty,
Cation-pi interactions involving aromatic amino acids.
2007,
Pubmed
Elbarbary,
An Egyptian family with H syndrome due to a novel mutation in SLC29A3 illustrating overlapping features with pigmented hypertrichotic dermatosis with insulin-dependent diabetes and Faisalabad histiocytosis.
2013,
Pubmed
Endres,
Residues Met89 and Ser160 in the human equilibrative nucleoside transporter 1 affect its affinity for adenosine, guanosine, S6-(4-nitrobenzyl)-mercaptopurine riboside, and dipyridamole.
2005,
Pubmed
Farooq,
Identification of two novel mutations in SLC29A3 encoding an equilibrative nucleoside transporter (hENT3) in two distinct Syrian families with H syndrome: expression studies of SLC29A3 (hENT3) in human skin.
2012,
Pubmed
Felipe,
Na+-dependent nucleoside transport in liver: two different isoforms from the same gene family are expressed in liver cells.
1998,
Pubmed
Frey,
Conformational changes in the lower palm domain of ASIC1a contribute to desensitization and RFamide modulation.
2013,
Pubmed
,
Xenbase
Gallivan,
Cation-pi interactions in structural biology.
1999,
Pubmed
Govindarajan,
Facilitated mitochondrial import of antiviral and anticancer nucleoside drugs by human equilibrative nucleoside transporter-3.
2009,
Pubmed
,
Xenbase
Govindarajan,
In situ hybridization and immunolocalization of concentrative and equilibrative nucleoside transporters in the human intestine, liver, kidneys, and placenta.
2007,
Pubmed
Gray,
The concentrative nucleoside transporter family, SLC28.
2004,
Pubmed
Hirschi,
Visualizing multistep elevator-like transitions of a nucleoside transporter.
2017,
Pubmed
Hsu,
Equilibrative nucleoside transporter 3 deficiency perturbs lysosome function and macrophage homeostasis.
2012,
Pubmed
Hyde,
The ENT family of eukaryote nucleoside and nucleobase transporters: recent advances in the investigation of structure/function relationships and the identification of novel isoforms.
2001,
Pubmed
Johnson,
Crystal structure of a concentrative nucleoside transporter from Vibrio cholerae at 2.4 Å.
2012,
Pubmed
Kang,
Human equilibrative nucleoside transporter-3 (hENT3) spectrum disorder mutations impair nucleoside transport, protein localization, and stability.
2010,
Pubmed
Larráyoz,
Characterization of the rat Na+/nucleoside cotransporter 2 and transport of nucleoside-derived drugs using electrophysiological methods.
2006,
Pubmed
,
Xenbase
Lee,
Identification of the mitochondrial targeting signal of the human equilibrative nucleoside transporter 1 (hENT1): implications for interspecies differences in mitochondrial toxicity of fialuridine.
2006,
Pubmed
Mangravite,
Localization of human equilibrative nucleoside transporters, hENT1 and hENT2, in renal epithelial cells.
2003,
Pubmed
,
Xenbase
Molho-Pessach,
The H syndrome is caused by mutations in the nucleoside transporter hENT3.
2008,
Pubmed
Morgan,
Mutations in SLC29A3, encoding an equilibrative nucleoside transporter ENT3, cause a familial histiocytosis syndrome (Faisalabad histiocytosis) and familial Rosai-Dorfman disease.
2010,
Pubmed
Mueller,
Histidine protonation and the activation of viral fusion proteins.
2008,
Pubmed
Ngo,
Ontogenic and longitudinal activity of Na(+)-nucleoside transporters in the human intestine.
2001,
Pubmed
Pastor-Anglada,
SLC28 genes and concentrative nucleoside transporter (CNT) proteins.
2008,
Pubmed
Pennycooke,
Differential expression of human nucleoside transporters in normal and tumor tissue.
2001,
Pubmed
Pettersen,
UCSF Chimera--a visualization system for exploratory research and analysis.
2004,
Pubmed
Priya,
H syndrome: novel and recurrent mutations in SLC29A3.
2010,
Pubmed
Ramot,
Early-onset sensorineural hearing loss is a prominent feature of H syndrome.
2010,
Pubmed
Ritzel,
Molecular cloning and functional expression of cDNAs encoding a human Na+-nucleoside cotransporter (hCNT1).
1997,
Pubmed
,
Xenbase
Rötzschke,
A pH-sensitive histidine residue as control element for ligand release from HLA-DR molecules.
2002,
Pubmed
Sali,
Comparative protein modelling by satisfaction of spatial restraints.
1993,
Pubmed
Slugoski,
A proton-mediated conformational shift identifies a mobile pore-lining cysteine residue (Cys-561) in human concentrative nucleoside transporter 3.
2008,
Pubmed
,
Xenbase
Slugoski,
Substituted cysteine accessibility method analysis of human concentrative nucleoside transporter hCNT3 reveals a novel discontinuous region of functional importance within the CNT family motif (G/A)XKX3NEFVA(Y/M/F).
2009,
Pubmed
,
Xenbase
Smith,
Electrophysiological characterization of a recombinant human Na+-coupled nucleoside transporter (hCNT1) produced in Xenopus oocytes.
2004,
Pubmed
,
Xenbase
Stennicke,
Effects of introduced aspartic and glutamic acid residues on the P'1 substrate specificity, pH dependence and stability of carboxypeptidase Y.
1994,
Pubmed
Visser,
Mutation of residue 33 of human equilibrative nucleoside transporters 1 and 2 alters sensitivity to inhibition of transport by dilazep and dipyridamole.
2002,
Pubmed
,
Xenbase
Visser,
Residues 334 and 338 in transmembrane segment 8 of human equilibrative nucleoside transporter 1 are important determinants of inhibitor sensitivity, protein folding, and catalytic turnover.
2007,
Pubmed
Wang,
Molecular mechanism of pH-dependent substrate transport by an arginine-agmatine antiporter.
2014,
Pubmed
Warraich,
Loss of equilibrative nucleoside transporter 1 in mice leads to progressive ectopic mineralization of spinal tissues resembling diffuse idiopathic skeletal hyperostosis in humans.
2013,
Pubmed
Young,
Human equilibrative nucleoside transporter (ENT) family of nucleoside and nucleobase transporter proteins.
2008,
Pubmed
Young,
The human concentrative and equilibrative nucleoside transporter families, SLC28 and SLC29.
2013,
Pubmed
de Jesus,
SLC29A3 mutation in a patient with syndromic diabetes with features of pigmented hypertrichotic dermatosis with insulin-dependent diabetes, H syndrome and Faisalabad histiocytosis.
2013,
Pubmed
